Barclays raised the firm’s price target on Emerson (EMR) to $112 from $104 and keeps an Underweight rating on the shares. The firm sees a narrowing in end market growth dispersion, which could also yield a narrowing in the dispersion of estimate revision momentum, and hence valuation multiples, across the multi-industry sector.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EMR:
- Emerson price target raised to $135 from $121 at Wells Fargo
- Emerson Electric: Poised for Growth with Innovative Solutions and Margin Expansion Potential
- Emerson price target raised to $150 from $135 at Mizuho
- Emerson price target raised to $133 from $113 at JPMorgan
- Emerson price target raised to $133 from $127 at Citi